The Zensights Federated Healthcare Advisory Panel explores how shifting global dynamics are reshaping access and strategic planning across the healthcare system.
Operations
Latest News
Advertisement
Advertisement
Investment is expected to bring approximately 1,000 new jobs at Novartis and 4,000 additional roles across the United States.
Eli Lilly CEO David Ricks to the BBC: “It feels like it'll be hard to come back from here."
The facility, which is set to open amid Biogen’s 50th anniversary, will integrate research and development, technical operations, and commercial teams into one location.
The investment, which is a 25% increase from previous years, will support three new advanced manufacturing facilities, expansions at existing sites, and R&D efforts.
Jonathon Whitton, AuD, PhD, VP, auditory global program head, Regeneron, discusses the promising results of DB-OTO in the CHORD trial for children with otoferlin-related hearing loss.
Advertisement
Advertisement
Trending on PharmExec
1
Pfizer Receives Unsolicited Mini-Tender Offer for 1 Million Shares from Tutanota: Report
2
Pharmaceutical Executive Daily: Pfizer Warns Shareholders to Reject Mini-Tender Offer
3
How Do Recent Actions from FDA Provide Insight to the Agency's Enforcement Posture?
4
Gilead Sciences Enters $2.1 Billion Definitive Agreement to Acquire Ouro Medicines
5